Amalgamated Bank Revolution Medicines, Inc. Transaction History

Amalgamated Bank

$11.7 Billion
Q1 2025

A detailed history of Amalgamated Bank transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 5,870 shares of RVMD stock, worth $235,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,870

Previous 5,707 2.86%

Holding current value

$235,974

Previous $250,000 16.8%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 25, 2025	BUY	$35.36 - $44.42 $5,763 - $7,240	163 Added 2.86%	5,870 $208,000
Q4 2024 Feb 04, 2025	BUY	$42.97 - $60.6 $18,691 - $26,361	435 Added 8.25%	5,707 $250,000
Q2 2024 Aug 12, 2024	BUY	$30.14 - $40.68 $11,001 - $14,848	365 Added 7.44%	5,272 $205,000
Q1 2024 Apr 23, 2024	SELL	$26.56 - $33.55 $360,897 - $455,877	-13,588 Reduced 73.47%	4,907 $158,000
Q4 2023 Feb 06, 2024	BUY	$18.35 - $34.12 $53,361 - $99,220	2,908 Added 18.66%	18,495 $530,000
Q3 2023 Nov 08, 2023	BUY	$25.17 - $35.05 $19,808 - $27,584	787 Added 5.32%	15,587 $431,000
Q2 2023 Aug 11, 2023	BUY	$20.28 - $27.0 $104,462 - $139,077	5,151 Added 53.38%	14,800 $395,000
Q1 2023 May 02, 2023	SELL	$20.76 - $30.09 $10,317 - $14,954	-497 Reduced 4.9%	9,649 $209,000
Q4 2022 Feb 10, 2023	BUY	$17.68 - $25.53 $3,200 - $4,620	181 Added 1.82%	10,146 $242,000
Q3 2022 Nov 09, 2022	BUY	$17.46 - $26.0 $29,210 - $43,498	1,673 Added 20.18%	9,965 $197,000
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $11,195 - $20,920	770 Added 10.24%	8,292 $162,000
Q1 2022 Jun 30, 2022	SELL	$17.31 - $26.4 $9,797 - $14,942	-566 Reduced 7.0%	7,522 $192,000
Q4 2021 Feb 15, 2022	SELL	$24.35 - $33.7 $2,410 - $3,336	-99 Reduced 1.21%	8,088 $204,000
Q3 2021 Oct 29, 2021	SELL	$23.95 - $33.41 $13,435 - $18,743	-561 Reduced 6.41%	8,187 $225,000
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $77,517 - $126,807	2,673 Added 44.0%	8,748 $278,000
Q1 2021 May 13, 2021	BUY	$37.21 - $54.43 $1,637 - $2,394	44 Added 0.73%	6,075 $279,000
Q4 2020 Feb 12, 2021	BUY	$30.19 - $45.49 $996 - $1,501	33 Added 0.55%	6,031 $238,000
Q3 2020 Oct 30, 2020	BUY	$22.61 - $34.8 $135,614 - $208,730	5,998 New	5,998 $209,000

Others Institutions Holding RVMD

# of Institutions

303

Shares Held

189M

Call Options Held

186K

Put Options Held

672K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.53B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Revolution Medicines, Inc. Transaction History